Peptide record

TPDB21193

Antibacterial Anticancer Toxicity modified_plain modified
14 source-reported length (unverified)
Basic Information
TPDB21193
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A modified multi-activity (Antibacterial, Anticancer, and Toxicity) peptide record curated from Peptipedia, without an available 3D structural model. Source-reported length: 14 (unverified).
Modified, details unspecified
Sequence
IDWKKLLDAAKQIX

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
14 source-reported length (unverified)
Evidence Records 2 records
Evidence 1 Activity

Activity

50% Cell death
Toxicity
>60 µM
Cytotoxic
50% Cell death | >60 | µM | target cell: Mouse fibroblasts NIH 3T3

Target

Mouse fibroblasts NIH 3T3

Source & Reference

NA
DBAASP
A novel analog of antimicrobial peptide Polybia-MPI, with thioamide bond substitution, exhibits increased therapeutic efficacy against cancer and diminished toxicity in mice. | Peptides | 2010
Evidence 2 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: NIH 3T3: 50% Cell death>60 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Peptides. 2010 Oct 31(10):1832-8.